E-LIB Suche - Ergebnisse für: Hamad, Nada

1

Cost-Effectiveness of Extracorporeal Photopheresis in Patie..:

Peacock, Adrian ; Dehle, Frances C. ; Mesa Zapata, Oscar A....
Journal of Health Economics and Outcomes Research. 11 (2024) 1 - p. , 2024

Link: https://doi.org/10.36469..

2

Attitudes towards COVID-19 Vaccination in Adults with Haema..:

Blennerhassett, Richard ; Hamad, Nada ; Grech, Lisa...
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

3

Indication and management of allogeneic haematopoietic stem..:

Kröger, Nicolaus ; Bacigalupo, Andrea ; Barbui, Tiziano...
The Lancet Haematology. 11 (2024) 1 - p. e62-e74 , 2024

Link: https://doi.org/10.1016/..

4

Poor reporting limited consideration of EDI in the Australi..:

Hewitt, Jessie ; Hamad, Nada ; Beecher, Claire..
Journal of Clinical Epidemiology. 170 (2024) - p. 111361 , 2024

Link: https://doi.org/10.1016/..

5

International Recommendations for Screening and Preventativ..:

Rotz, Seth J. ; Bhatt, Neel S. ; Hamilton, Betty K....
Transplantation and Cellular Therapy. 30 (2024) 4 - p. 349-385 , 2024

Link: https://doi.org/10.1016/..

6

Continuous and differential improvement in worldwide access..:

Atsuta, Yoshiko ; Baldomero, Helen ; Neumann, Daniel...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

7

Peripheral Blood Haploidentical Allogeneic Stem Cell Transp..:

Abadir, Edward ; Othman, Jad ; Kwan, John...
Transplantation and Cellular Therapy. 30 (2024) 3 - p. 334.e1-334.e7 , 2024

Link: https://doi.org/10.1016/..

8

Poor outcomes for trial‐ineligible patients receiving polat..:

Shaw, Briony ; Chung, Eliza ; Wellard, Cameron...
eJHaem. 5 (2024) 2 - p. 325-332 , 2024

Link: https://doi.org/10.1002/..

9

Cost-Effectiveness of Extracorporeal Photopheresis in Patie..:

Peacock, Adrian ; Dehle, Frances ; Mesa Zapata, Oscar...
Journal of Health Economics and Outcomes Research. , 2024

Link: https://doi.org/10.36469..

10

Outcomes of human immunodeficiency virus‐associated Burkitt..:

Lim, Kenneth J. C. ; Di Ciaccio, Pietro ; Polizzotto, Mark N....
British Journal of Haematology. 201 (2023) 5 - p. 865-873 , 2023

Link: https://doi.org/10.1111/..

11

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFI..:

Shaw, Briony ; Chung, Eliza ; Wellard, Cameron...
HemaSphere. 7 (2023) S3 - p. e24670ab , 2023

Link: https://doi.org/10.1097/..

12

Characteristics and Outcomes of Older Patients With Classic..:

Goh, Zhong ; Latimer, Maya ; Lewis, Katharine L....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 5 - p. 370-378 , 2023

Link: https://doi.org/10.1016/..

13

An international real-world analysis of relapsed/refractory..:

Farooq, Faheem ; Brandt, Justin S. ; Cardonick, Elyce...
Blood Advances. 7 (2023) 18 - p. 5480-5484 , 2023

Link: https://doi.org/10.1182/..

14

Association between the choice of the conditioning regimen ..:

Murthy, Guru Subramanian Guru ; Kim, Soyoung ; Estrada-Merly, Noel...
Haematologica. 108 (2023) 7 - p. 1900-1908 , 2023

Link: https://doi.org/10.3324/..

15

ANZTCT consensus position statement on ruxolitinib in stero..:

Hamad, Nada ; Bilmon, Ian ; Chee, Lynette...
Internal Medicine Journal. 53 (2023) 12 - p. 2319-2329 , 2023

Link: https://doi.org/10.1111/..